Status:

NOT_YET_RECRUITING

Navigating the Clinical Research Process for Mild Cognitive Impairment

Lead Sponsor:

Power Life Sciences Inc.

Conditions:

Mild Cognitive Impairment

Eligibility:

All Genders

18+ years

Brief Summary

Participation in medical research usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demogr...

Eligibility Criteria

Inclusion

  • Confirmed diagnosis of mild cognitive impairment
  • Participant must be 18 years of age or older
  • Participant must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests, and other requirements of the study.

Exclusion

  • Pregnant or lactating woman
  • Participant is actively receiving study therapy in another
  • Inability to provide written informed consent

Key Trial Info

Start Date :

February 1 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

February 1 2027

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT06207903

Start Date

February 1 2025

End Date

February 1 2027

Last Update

January 17 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Power Life Sciences

San Francisco, California, United States, 94107

Navigating the Clinical Research Process for Mild Cognitive Impairment | DecenTrialz